Home | Overview | Ortho-tag | Ortho-tag Biosensor | Ortho-tag Touch Probe | Ortho-tag Benefits | Ortho-tag Card | Joint Registry | Published Research | Media | Contact Ortho-tag
Ortho-tag Biosensor

Prosthetic joint infections (PJI) occurs in approximately 1% to 2 % of all primary total hip and knee arthroplasties. Given the increasing number of total joints performed throughout the United States, total hip and knee infections create a significant burden on the health care system. The cost of treating PJI in the United States alone is approximately $200 million per year.


Ortho-tag is developing integrated biosensor technology on its TNFC tags to detect (in real-time) the early progression of joint infections by analyzing the tissue surrounding the implanted prosthetic joint and communicating the reading through Transcutaneous Near Field Communication (TNFC) technology.  

This product has not yet been cleared for sale in the United States by the FDA